Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents
- 2 May 1999
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 82 (2-3), 231-239
- https://doi.org/10.1016/s0163-7258(98)00066-7
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma CellsImmunity, 1999
- Suppression of Experimental Autoimmune Encephalomyelitis by Tyrphostin AG-556Experimental Neurology, 1998
- PDGF-Receptor Tyrosine Kinase Blocker AG1295 Selectively Attenuates Smooth Muscle Cell Growth In Vitro and Reduces Neointimal Formation After Balloon Angioplasty in SwineCirculation, 1998
- The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathwaysProceedings of the National Academy of Sciences, 1996
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996
- Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor ReceptorJournal of Medicinal Chemistry, 1996
- Tyrphostins suppress the growth of psoriatic keratinocytesExperimental Dermatology, 1995
- RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.Proceedings of the National Academy of Sciences, 1995
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994
- The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.The Journal of cell biology, 1991